Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg
Description
In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention (7 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
Dr Gabby Mahoney
Allergen Introduction – Practical Tips for GPs
Dr Terri Foran
Oral Contraception Update
A/Prof Karam Kostner
What do we do With High Triglycerides?
Prof Andrew Sindone
An Update on Heart Failure in Primary Care
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
